Search

Your search keyword '"Metanephrine urine"' showing total 487 results

Search Constraints

Start Over You searched for: Descriptor "Metanephrine urine" Remove constraint Descriptor: "Metanephrine urine"
487 results on '"Metanephrine urine"'

Search Results

151. Long-term morphological, hormonal, and clinical follow-up in a single unit on 118 patients with adrenal incidentalomas.

152. Pheochromocytoma and pregnancy: a rare but dangerous combination.

153. Pilot quality assurance programme for plasma metanephrines.

154. Urinary catecholamine and metadrenaline to creatinine ratios in dogs with a phaeochromocytoma.

155. Adrenal incidentaloma, clinical, metabolic, follow-up aspects: single centre experience.

156. A study on the stability of urinary free catecholamines and free methyl-derivatives at different pH, temperature and time of storage.

157. High prevalence of obesity in patients with non-functioning adrenal incidentalomas.

158. Prospective evaluation of tumor size and hormonal status in adrenal incidentalomas.

159. Interactive medical case. A crisis in late pregnancy.

160. The value of immunoassays for metanephrines in the biochemical diagnosis of pheochromocytomas.

161. Dietary influences on plasma and urinary metanephrines: implications for diagnosis of catecholamine-producing tumors.

162. Pheochromocytoma, papillary thyroid carcinoma.

163. [Pheochromocytoma in 8-year observation at a single endocrinological center in Wroclaw].

164. Ordering pattern and performance of biochemical tests for diagnosing pheochromocytoma between 2000 and 2008.

165. Reference intervals for urinary catecholamines and metabolites from birth to adulthood.

166. Simultaneous measurement of urinary metanephrines and catecholamines by liquid chromatography with tandem mass spectrometric detection.

167. Pheochromocytoma crisis due to glucocorticoid administration: a case report and review of the literature.

168. [Clinical and biological work-up of adrenal incidentalomas].

169. Evaluation of adrenomedullary function in patients with congenital adrenal hyperplasia.

170. Biochemically silent abdominal paragangliomas in patients with mutations in the succinate dehydrogenase subunit B gene.

171. [Pheochromocytoma in end-stage renal disease patient treated by peritoneal dialysis].

173. Evaluation of a urinary metanephrines reagent kit: an automated approach.

174. Current progress and future challenges in the biochemical diagnosis and treatment of pheochromocytomas and paragangliomas.

175. A pheochromocytoma with normal clonidine-suppression test: how difficult the biochemical diagnosis?

176. An apparent phaeochromocytoma and abnormal thyroid function tests.

177. Extra-adrenal and adrenal pheochromocytomas associated with a germline SDHC mutation.

178. Biochemical detection of phaeochromocytoma: why are we continuing to ignore the evidence?

179. Plasma chromogranin A or urine fractionated metanephrines follow-up testing improves the diagnostic accuracy of plasma fractionated metanephrines for pheochromocytoma.

180. Comparison of diagnostic accuracy of urinary free metanephrines, vanillyl mandelic Acid, and catecholamines and plasma catecholamines for diagnosis of pheochromocytoma.

181. Ectopic ACTH syndrome caused by pheochromocytoma: computed tomography-guided percutaneous ethanol injection as an alternative treatment.

182. [Difficult diagnosis of a pancreatic paraganglioma].

183. Adrenal incidentaloma, borderline elevations of urine or plasma metanephrine levels, and the "subclinical" pheochromocytoma.

184. Parkinson's disease: the effect of L-dopa therapy on urinary free catecholamines and metabolites.

185. Asymptomatic bilateral adrenal pheochromocytoma in a patient with a germline V804M mutation in the RET proto-oncogene.

186. [Clinical study of 38 cases of pheochromocytoma --correlation between the instability of intraoperative blood pressure and 24-hour urinary vanillylmandelic acid].

187. Hypertension associated with large bilateral adrenal masses.

188. Non-invasive assessment of cardioregulatory autonomic functions in children with epilepsy.

189. The incidentally discovered adrenal mass.

191. Urinary catecholamine and metanephrine to creatinine ratios in healthy dogs at home and in a hospital environment and in 2 dogs with pheochromocytoma.

192. The diagnostic efficacy of urinary fractionated metanephrines measured by tandem mass spectrometry in detection of pheochromocytoma.

193. Is it a pheochromocytoma?

194. Stability of urinary fractionated metanephrines and catecholamines during collection, shipment, and storage of samples.

195. Effect of stress on erythrocyte deformability, influence of gender and menstrual cycle.

196. The effect of valsartan, an angiotensin II receptor antagonist, on portal and systemic hemodynamics and on renal function in liver cirrhosis.

198. Measurement of urinary metanephrines to screen for pheochromocytoma in an unselected hospital referral population.

199. Utility of plasma free metanephrines in diagnosis of factitious pheochromocytoma.

200. Cortisol production rate in posttraumatic stress disorder.

Catalog

Books, media, physical & digital resources